Iovance Biotherapeutics, Inc.
IOVA
$3.06
-$0.01-0.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.69% | 9.99% | 64.43% | -43.13% | -40.69% |
| Total Receivables | 45,820.53% | -- | 95,669.70% | -- | -- |
| Inventory | 396.72% | 319.55% | 186.56% | -- | -- |
| Prepaid Expenses | -29.10% | -43.88% | -28.44% | -0.02% | 140.10% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 48.46% | 30.32% | 75.44% | -39.55% | -35.75% |
|
|
|||||
| Total Current Assets | 48.46% | 30.32% | 75.44% | -39.55% | -35.75% |
| Net Property, Plant & Equipment | -6.95% | -0.08% | -0.05% | 1.64% | -0.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 23.18% | 37.13% | 25.39% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -89.91% | -90.05% | -89.98% | 0.86% | 907.71% |
| Total Assets | 16.67% | 16.29% | 27.34% | 5.46% | 17.53% |
|
|
|||||
| Total Accounts Payable | -16.95% | 64.40% | -34.47% | -18.60% | 24.51% |
| Total Accrued Expenses | 12.27% | 29.25% | 43.66% | 22.89% | 46.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 65.82% | 10.35% | 5.25% | -12.18% | -38.21% |
| Total Finance Division Other Current Liabilities | 176.90% | -58.18% | -64.71% | -75.03% | -62.57% |
| Total Other Current Liabilities | 176.90% | -58.18% | -64.71% | -75.03% | -62.57% |
| Total Current Liabilities | 10.91% | 29.80% | 5.64% | -4.65% | 20.57% |
|
|
|||||
| Total Current Liabilities | 10.91% | 29.80% | 5.64% | -4.65% | 20.57% |
| Long-Term Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -33.87% | -2.38% | 0.58% | 3.85% | -6.64% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 86.29% | 75.63% | 57.62% | -- | -- |
| Total Liabilities | 2.19% | 22.07% | 9.54% | 20.22% | 19.10% |
|
|
|||||
| Common Stock & APIC | 19.33% | 18.77% | 26.69% | 19.74% | 25.40% |
| Retained Earnings | -18.49% | -21.62% | -24.70% | -26.83% | -28.31% |
| Treasury Stock & Other | -141.41% | 278.54% | 61.85% | 192.06% | 380.04% |
| Total Common Equity | 21.52% | 14.75% | 32.83% | 1.97% | 17.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 21.52% | 14.75% | 32.83% | 1.97% | 17.01% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 21.52% | 14.75% | 32.83% | 1.97% | 17.01% |
|
|
|||||